Pre-Employment Drug Testing: Process, Timing, and Rights

Pre-employment drug testing is usually one condition in a defined hiring process, but the applicable rules depend on the employer, job, and location. DOT-regulated safety-sensitive work follows federal procedures, while nonregulated employers must consider state and local restrictions, policy, and antidiscrimination law.

This guide is part of Workplace Drug Testing.

When testing occurs

Many employers test after a conditional offer and before the applicant begins work. Regulated programs define when a negative result must be received before safety-sensitive functions begin. Nonregulated timing can be affected by state law, local fair-chance or cannabis rules, and the employer’s written policy.

What applicants should receive

Depending on the program, applicants may receive notice of the policy, testing instructions, a consent or acknowledgment form, collection-site information, deadlines, and a description of consequences. The employer should use consistent criteria for similarly situated applicants and provide required opportunities for confirmation or review.

Typical process

  1. A conditional offer or test instruction identifies the requirement.
  2. The applicant reports to the collection site with identification.
  3. The specimen is collected and documented.
  4. The laboratory performs the ordered panel and confirms non-negative screens when required.
  5. An MRO contacts the applicant if medical review is needed.
  6. The employer receives the final authorized result and applies the hiring policy.

Specimens and panels

Urine is common, and oral-fluid testing is available in some programs. Hair and other specimens may be used in nonregulated testing where lawful and appropriate. The panel should be disclosed or identifiable through policy, and a “five-panel” label should not be assumed to cover every opioid or prescription.

Compare Drug Testing Methods and Drug-Testing Panels.

Prescription medications

Applicants should not stop prescribed medication to influence a test. In a program with medical review, prescription information should generally go to the MRO or other authorized medical reviewer rather than the hiring manager. A legitimate medical explanation may affect the final verified result, while separate safety questions may require a lawful individualized process.

Cannabis

State and local laws vary significantly. Some jurisdictions restrict pre-employment cannabis testing or adverse action based on off-duty use, with exceptions for safety-sensitive work or federal obligations. A state’s legalization of cannabis does not automatically prohibit testing, and it does not override DOT rules.

ADA and discrimination considerations

Under the ADA, a test for current illegal drug use is not a medical examination. However, an employer can create liability by misclassifying lawful medication use, asking impermissible disability questions, or applying a policy discriminatorily. Other federal, state, or local protections may also apply.

Unexpected results

Determine whether a reported finding is an initial screen, confirmed laboratory result, or final verified result. Respond promptly to the MRO, document legitimate prescriptions, and observe deadlines for a split specimen or review. A new test collected later may not resolve the original specimen.

Applicant checklist

  • Read the policy and deadline.
  • Bring required identification.
  • Take medication as prescribed unless the prescriber advises otherwise.
  • Keep the collection receipt or identifying copy.
  • Respond promptly to calls from the MRO.
  • Request the applicable review procedure if the result is unexpected.

Employer checklist

  • Confirm the rule in every hiring location.
  • Use consistent post-offer timing where required.
  • Identify safety-sensitive and regulated positions correctly.
  • Use an appropriate laboratory, confirmation, and MRO process.
  • Limit result access and document decisions.

Continue with Employee Rights and Privacy and Understanding Results.

Sources

Legal and evidence review: October 29, 2026. Verify current federal, state, and local requirements.